KNSA
NASDAQ · Biotechnology
Kiniksa Pharmaceuticals Inte
$78.13
+0.89 (+1.15%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+116.55%
YTD
+86.00%
Open$77.12
Previous Close$77.24
Day High$78.73
Day Low$75.90
52W High$82.94
52W Low$35.20
Volume—
Avg Volume577.8K
Market Cap6.19B
P/E Ratio76.74
EPS$0.98
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$42.51
Above
SMA 200
$35.71
Above
RSI (14)
68.7
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
14 analysts
Price Target
-7.0% upside
Current
$78.13
$78.13
Target
$72.69
$72.69
$47.11
$72.69 avg
$100.82
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 687.48M | 472.66M | 434.64M |
| Net Income | 59.87M | 37.05M | -80,259,876 |
| Profit Margin | 8.7% | 8.3% | -18.5% |
| EBITDA | 79.93M | 52.20M | -90,838,119 |
| Free Cash Flow | — | — | -118,111,706 |
| Rev Growth | +45.5% | +45.5% | +6.7% |
| Debt/Equity | — | — | 0.75 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.48 | +0.20% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $393.16 | +1.95% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $150.56 | +0.30% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $510.72 | +0.47% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $798.17 | +1.70% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $244.32 | +1.99% | 40.0 | 32.33B |